STOCK TITAN
  1. Home
  2. SEC Filings
  3. LRCX
  4. [Form 4] LAM RESEARCH CORP Insider Trading Activity

Lam Research director sells 54,500 shares

Lam Research Corp director Eric Brandt reported open-market sales of 54,500 shares of common stock on June 12, 2026.

Filing Impact
(Very High)
Filing Sentiment

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment worksHow the balance works

Form Type
4

Rhea-AI Filing Summary

Lam Research Corp director Eric Brandt reported open-market sales of 54,500 shares of common stock on June 12, 2026. The trades were executed under a pre-arranged Rule 10b5-1 trading plan adopted on February 6, 2026, at prices ranging from $355.39 to $373.36 per share. Following these transactions, he directly owns 144,705 shares, including shares subject to unvested restricted stock units.

Insider BRANDT ERIC
Role Director
Sold 54,500 shs ($20.01M)
Type Security Shares Price Value
Sale Common Stock 300 $355.71 $107K
Sale Common Stock 1,393 $357.24 $498K
Sale Common Stock 1,100 $357.98 $394K
Sale Common Stock 3,828 $359.08 $1.37M
Sale Common Stock 1,906 $360.15 $686K
Sale Common Stock 819 $361.21 $296K
Sale Common Stock 2,708 $362.40 $981K
Sale Common Stock 2,345 $363.33 $852K
Sale Common Stock 2,300 $364.41 $838K
Sale Common Stock 1,200 $365.16 $438K
Sale Common Stock 5,803 $367.01 $2.13M
Sale Common Stock 4,030 $368.03 $1.48M
Sale Common Stock 4,198 $369.16 $1.55M
Sale Common Stock 5,037 $370.27 $1.87M
Sale Common Stock 8,233 $371.17 $3.06M
Sale Common Stock 7,700 $372.23 $2.87M
Sale Common Stock 1,600 $373.09 $597K
Holdings After Transaction: Common Stock — 144,705 shares (Direct)
Footnotes (19)
  1. F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.
  2. F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $355.39 to $356.02, inclusive
  3. F3. The amount reported includes shares subject to unvested restricted stock units.
  4. F4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $356.685 to $357.67, inclusive
  5. F5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $357.68 to $358.35, inclusive
  6. F6. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $358.73 to $359.54, inclusive
  7. F7. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $359.84 to $360.79, inclusive
  8. F8. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $360.85 to $361.83, inclusive
  9. F9. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $361.87 to $362.82, inclusive
  10. F10. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $363.77, inclusive
  11. F11. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $364.85, inclusive
  12. F12. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $364.98 to $365.67, inclusive
  13. F13. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $366.56 to $367.55, inclusive
  14. F14. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $367.62 to $368.49, inclusive
  15. F15. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.70 to $369.64, inclusive
  16. F16. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $369.70 to $370.69, inclusive
  17. F17. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $370.70 to $371.59, inclusive
  18. F18. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $371.77 to $372.76, inclusive
  19. F19. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $372.79 to $373.36, inclusive
Shares sold 54,500 shares Open-market sales on June 12, 2026
Lowest sale price $355.39/share Price range from weighted average footnotes
Highest sale price $373.36/share Price range from weighted average footnotes
Shares owned after transactions 198,905 shares Direct holdings after June 12, 2026 sales
Number of sale transactions 17 transactions Non-derivative open-market sales coded “S”
Net share change -54,500 shares Net-sell direction in transaction summary
Rule 10b5-1 trading plan regulatory
"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"The price reported in Column 4 is a weighted average sale price."
restricted stock units financial
"The amount reported includes shares subject to unvested restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Lam Research (LRCX) director Eric Brandt report in this Form 4?
Eric Brandt reported selling 54,500 shares of Lam Research common stock in open-market transactions. The trades occurred on June 12, 2026, under a pre-arranged Rule 10b5-1 plan and were executed at prices between $355.39 and $373.36 per share.

How many Lam Research (LRCX) shares does Eric Brandt hold after the reported sales?
After the reported transactions, Eric Brandt directly holds 198,905 Lam Research common shares. This figure includes shares subject to unvested restricted stock units, as disclosed, giving investors a view of his remaining direct equity stake in the company.

Were Eric Brandt’s Lam Research (LRCX) share sales pre-planned?
Yes. The filing states the transactions were effected under a Rule 10b5-1 trading plan adopted on February 6, 2026. Such plans allow insiders to schedule trades in advance, helping separate personal trading decisions from day-to-day market information.

At what prices did Eric Brandt sell his Lam Research (LRCX) shares?
The reported prices are weighted average sale prices for multiple trades. According to the footnotes, the shares were sold in transactions with prices ranging from $355.39 to $373.36 per share across several narrow price bands.

Does Eric Brandt’s Lam Research (LRCX) holding include restricted stock units?
Yes. A footnote explains that the amount reported includes shares subject to unvested restricted stock units. This means part of his disclosed ownership reflects equity awards that are still in the process of vesting over time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Accepted by SEC EDGAR
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BRANDT ERIC
(Last)(First)(Middle)
C/O LAM RESEARCH CORPORATION
4650 CUSHING PARKWAY
(Street)
FREMONT CALIFORNIA 94538
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
LAM RESEARCH CORP [ LRCX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/12/2026S300(1)D$355.71(2)198,905(3)D
Common Stock06/12/2026S1,393(1)D$357.24(4)197,512(3)D
Common Stock06/12/2026S1,100(1)D$357.98(5)196,412(3)D
Common Stock06/12/2026S3,828(1)D$359.08(6)192,584(3)D
Common Stock06/12/2026S1,906(1)D$360.15(7)190,678(3)D
Common Stock06/12/2026S819(1)D$361.21(8)189,859(3)D
Common Stock06/12/2026S2,708(1)D$362.4(9)187,151(3)D
Common Stock06/12/2026S2,345(1)D$363.33(10)184,806(3)D
Common Stock06/12/2026S2,300(1)D$364.41(11)182,506(3)D
Common Stock06/12/2026S1,200(1)D$365.16(12)181,306(3)D
Common Stock06/12/2026S5,803(1)D$367.01(13)175,503(3)D
Common Stock06/12/2026S4,030(1)D$368.03(14)171,473(3)D
Common Stock06/12/2026S4,198(1)D$369.16(15)167,275(3)D
Common Stock06/12/2026S5,037(1)D$370.27(16)162,238(3)D
Common Stock06/12/2026S8,233(1)D$371.17(17)154,005(3)D
Common Stock06/12/2026S7,700(1)D$372.23(18)146,305(3)D
Common Stock06/12/2026S1,600(1)D$373.09(19)144,705(3)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.
2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $355.39 to $356.02, inclusive
3. The amount reported includes shares subject to unvested restricted stock units.
4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $356.685 to $357.67, inclusive
5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $357.68 to $358.35, inclusive
6. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $358.73 to $359.54, inclusive
7. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $359.84 to $360.79, inclusive
8. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $360.85 to $361.83, inclusive
9. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $361.87 to $362.82, inclusive
10. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $363.77, inclusive
11. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $364.85, inclusive
12. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $364.98 to $365.67, inclusive
13. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $366.56 to $367.55, inclusive
14. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $367.62 to $368.49, inclusive
15. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.70 to $369.64, inclusive
16. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $369.70 to $370.69, inclusive
17. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $370.70 to $371.59, inclusive
18. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $371.77 to $372.76, inclusive
19. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $372.79 to $373.36, inclusive
Remarks:
Marta Woods by Power of Attorney06/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

Keep reading

More on LRCX

All LRCX news

Trending in the feed

LQDA
Liquidia Announces Global Settlement Resolving All Pending Litigation with United Therapeutics, Ensuring Continued Commercialization of YUTREPIA in PAH Open the live feed